Studies Under Development

The following studies are under development. Use the links in the box on the left for information on each of the studies under development by the PASA Consortium. 

AS170014-A3 Ismene Petrakis, M.D. 

Study Type: Phase 1/2 double blinded, placebo-controlled, within-subjects crossover dose exploration design
Protocol:Effect of Sublingual formulation of Dexmedetomidine HCl (BXCL 501) on Ethanol in Healthy Humans and Heavy Drinkers
Participating Site: VA Connecticut Healthcare System

AS170014-A4 Luba Yammine, Ph.D. 

Study Type:Phase II Randomized Controlled Trial (RCT)
Protocol:An Aldehyde Dehydrogenase 2 Inhibitor for PTSD and AUD
Participating Site:Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC)

AS140026-A3a Dewleen Baker, M.D. and Victoria Risbrough, Ph.D.

Study Type: Phase II Clinical Proof of Concept Trial 
Protocol: Efficacy and Safety Study of PT150 (formerly ORG 34517) in Veterans with Comorbid PTSD and AUD
Participating Site: VA San Diego Health Care System (VASDHS)